Mechanism and research progress of mesenchymal stem cells in treatment of COVID-19
10.3969/j.issn.1000-484X.2024.01.034
- VernacularTitle:间充质干细胞治疗新型冠状病毒肺炎的机制及研究进展
- Author:
Xiaosui LING
1
;
Haiping HE
;
Fan LI
;
Lihua ZHANG
Author Information
1. 昆明理工大学医学院,昆明 650500
- Keywords:
Mesenchymal stem cells;
COVID-19;
Clinical trials
- From:
Chinese Journal of Immunology
2024;40(1):220-224
- CountryChina
- Language:Chinese
-
Abstract:
Coronavirus disease 2019(COVID-19)is highly infectious,severe and critically ill patients have high mortality and lack specific treatment,so it is urgent to find safe and effective treatment methods.Mesenchymal stem cells(MSCs)have biologi-cal properties such as immune regulation,tissue repair,regeneration,migration and homing,antiviral and anti-inflammatory.At present,studies on use of MSCs in treatment of COVID-19 have been gradually carried out.This paper reviews pathogenesis of 2019 novel coronavirus(2019-nCoV),potential regulatory mechanisms and challenges of MSCs in treatment of COVID-19.